Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
2011; Oxford University Press; Volume: 18; Issue: 5 Linguagem: Inglês
10.1002/ibd.21853
ISSN1536-4844
AutoresHaruhiko Ogata, Jun Kato, Fumihito Hirai, Nobuyuki Hida, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Koyanagi, Toshifumi Hibi∥,
Tópico(s)Liver Diseases and Immunity
ResumoBackgroundWe report a multicenter study of oral tacrolimus (FK506) therapy in steroid-refractory ulcerative colitis (UC).
Referência(s)